ArticleJournal of pharmacokinetics and pharmacodynamics2006

A mechanism-based disease progression model for comparison of long-term effects of pioglitazone, metformin and gliclazide on disease processes underlying Type 2 Diabetes Mellitus.

Willem de Winter et al.PubMed ↗Publisher ↗

No numbers read from the abstract.